Stay updated on Ipilimumab/Nivolumab in High-Risk Ocular Melanoma Clinical Trial

Sign up to get notified when there's something new on the Ipilimumab/Nivolumab in High-Risk Ocular Melanoma Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Ipilimumab/Nivolumab in High-Risk Ocular Melanoma Clinical Trial page

  1. Check
    yesterday
    Change Detected
    Summary
    Revision tag updated from v3.6.5 to v3.6.6, indicating a software revision of the site. This is a maintenance update and does not change the displayed study details or workflow.
    Difference
    0.1%
    Check dated 2026-08-29T19:43:56.000Z thumbnail image
  2. Check
    8 days ago
    No Change Detected
  3. Check
    15 days ago
    No Change Detected
  4. Check
    22 days ago
    Change Detected
    Summary
    Revision label on the page updated to v3.6.5, replacing the previous v3.6.4. This signals a minor update to the study record metadata rather than changes to study details.
    Difference
    0.1%
    Check dated 2026-08-08T18:25:37.000Z thumbnail image
  5. Check
    36 days ago
    Change Detected
    Summary
    Revision label updated from v3.6.3 to v3.6.4 in the page footer, indicating a small site update with no changes to study details or navigation.
    Difference
    0.1%
    Check dated 2026-07-25T10:25:03.000Z thumbnail image
  6. Check
    58 days ago
    Change Detected
    Summary
    The page now shows revision: v3.6.3, replacing the previous v3.6.2. This indicates a minor metadata/format update to the page rather than a substantive change to content.
    Difference
    0.1%
    Check dated 2026-07-03T23:55:08.000Z thumbnail image
  7. Check
    65 days ago
    Change Detected
    Summary
    The page's revision tag was updated from v3.6.0 to v3.6.2, indicating a refreshed or corrected version of the study record.
    Difference
    0.1%
    Check dated 2026-06-26T19:38:14.000Z thumbnail image
  8. Check
    79 days ago
    Change Detected
    Summary
    The page now lists the investigator and sponsor names as additions and adds several navigation/help items (How to Read a Study Record, Common Questions, How to Join a Study) along with an updated label (Intervention/Treatment) and a new revision tag (Revision: v3.6.0). It also removes older labels and references (Last known status was, Verified) and the prior version tag (Revision: v3.5.5).
    Difference
    1%
    Check dated 2026-06-12T12:37:30.000Z thumbnail image

Stay in the know with updates to Ipilimumab/Nivolumab in High-Risk Ocular Melanoma Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Ipilimumab/Nivolumab in High-Risk Ocular Melanoma Clinical Trial page.